Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease

BA Noble, RSK Loh, S MacLennan… - British Journal of …, 2004 - bjo.bmj.com
Aims: To evaluate the efficacy of 50% autologous serum drops against conventional
treatment in ocular surface disorders refractory to normal treatments in a prospective …

Autologous serum eye drops for ocular surface disorders

G Geerling, S Maclennan, D Hartwig - British Journal of …, 2004 - bjo.bmj.com
Tears have antimicrobial, nourishing, mechanical, and optical properties. They contain
components such as growth factors, fibronectin, and vitamins to support proliferation …

Autologous serum eye drops for the treatment of ocular surface disease

AA Azari, CJ Rapuano - Eye & contact lens, 2015 - journals.lww.com
Objective: To examine the evidence for the role of autologous serum eye drops (ASD) in
disease of the ocular surface. Methods: A search of the literature published through May …

Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies

F Semeraro, E Forbice, O Braga, A Bova… - BioMed research …, 2014 - Wiley Online Library
Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular
surface diseases not improved by conventional therapy. Methods. We analyzed two …

Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies

AC Poon, G Geerling, JKG Dart, GE Fraenkel… - British Journal of …, 2001 - bjo.bmj.com
BACKGROUND/AIMS Autologous serum drops have been reported to be beneficial in
keratoconjunctivitis sicca (KCS) and persistent epithelial defects (PED). A clinical pilot study …

[HTML][HTML] Autologous serum for ocular surface diseases

GG Quinto, M Campos, A Behrens - Arquivos brasileiros de …, 2008 - SciELO Brasil
Autologous serum has been used to treat dry eye syndrome for many years. It contains
several growth factors, vitamins, fibronectin and other components that have been …

A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders

R Lagnado, AJ King, F Donald, HS Dua - British Journal of …, 2004 - bjo.bmj.com
Aim: To assess microbial contamination of 20% autologous serum (AS) eye drops used in a
hospital inpatient setting. Method: 14 patients received autologous serum drops from 4 to 14 …

Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American Academy of Ophthalmology

RM Shtein, JF Shen, AN Kuo, KM Hammersmith, JY Li… - Ophthalmology, 2020 - Elsevier
Purpose To describe the safety and effectiveness of using autologous serum-based eye
drops for the treatment of severe dry eye and persistent corneal epithelial defect. Methods …

Comparison of autologous serum eye drops with different diluents

YK Cho, W Huang, GY Kim, BS Lim - Current eye research, 2013 - Taylor & Francis
Purpose: To compare the effect of autologous serum eye drops with different diluents in
patients with dry eyes and persistent epithelial defects. Methods: Patients of Sjögren's …

Controlled study of the use of autologous serum in dry eye patients

N Tananuvat, M Daniell, LJ Sullivan, Q Yi, P McKelvie… - Cornea, 2001 - journals.lww.com
Purpose. To determine the efficacy and safety of topical autologous serum as a treatment of
dry eye patients. Methods. A 2-month, prospective, single-masked, placebo-controlled study …